Ecosystem News Sree Batchu 5/28/21 Ecosystem News Sree Batchu 5/28/21 FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Read More Industry News Sree Batchu 5/10/21 Industry News Sree Batchu 5/10/21 Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate Read More Industry News Sree Batchu 3/11/21 Industry News Sree Batchu 3/11/21 A Liquid 'Shield' Used on Ebola Now Has FDA Clearance to Make Handling COVID Tests Safer for Lab Workers Read More Industry News Sree Batchu 3/8/21 Industry News Sree Batchu 3/8/21 FDA Approves Gilead/Kite's Yescarta as First CAR-T for Follicular Lymphoma Read More Ecosystem News Jessica Barnette 7/24/20 Ecosystem News Jessica Barnette 7/24/20 U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Read More
Ecosystem News Sree Batchu 5/28/21 Ecosystem News Sree Batchu 5/28/21 FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Read More
Industry News Sree Batchu 5/10/21 Industry News Sree Batchu 5/10/21 Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate Read More
Industry News Sree Batchu 3/11/21 Industry News Sree Batchu 3/11/21 A Liquid 'Shield' Used on Ebola Now Has FDA Clearance to Make Handling COVID Tests Safer for Lab Workers Read More
Industry News Sree Batchu 3/8/21 Industry News Sree Batchu 3/8/21 FDA Approves Gilead/Kite's Yescarta as First CAR-T for Follicular Lymphoma Read More
Ecosystem News Jessica Barnette 7/24/20 Ecosystem News Jessica Barnette 7/24/20 U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma Read More